KISSEI PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,655 JPY | +1.67% |
|
+3.39% | +18.28% |
| 20/03 | Kissei Pharmaceutical Completes 6 Billion Yen Buyback Program | MT |
| 19/03 | Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023. | CI |
Chart calendar Kissei Pharmaceutical Co., Ltd.
fc8b40a3d5c39681fb.UUNuCVtGAOrtgqpcQEjEZcLGkg-FudUWqCCmNEev9E0.NyU4ZWs_UICYzNgWFSyFBJKg22nh9oFh3WTQdimXtyQALyJ5awJSx4_A5w~3b9ad1681314a6a464d4f488823ad7fb
Upcoming events on Kissei Pharmaceutical Co., Ltd.
Past events on Kissei Pharmaceutical Co., Ltd.
| 28/03/2024 | Final dividend |
| 30/01/2024 | Q3 2023 Earnings Release |
| 06/11/2023 | Q2 2023 Earnings Release |
| 28/09/2023 | Ex-dividend day for dividende intermédiaire |
| 31/07/2023 | Q1 2023 Earnings Release |
| 22/06/2023 06:30 am | Annual General Meeting |
| 08/05/2023 | Q4 2022 Earnings Release |
| 30/03/2023 | Ex-dividend day for final dividend |
| 31/01/2023 | Q3 2022 Earnings Release |
| 08/11/2022 | Interim 2022 Earnings Call |
| 08/11/2022 | Interim 2022 Earnings Release |
| 29/09/2022 | Ex-dividend day for dividende intermédiaire |
| 01/08/2022 | Q1 2022 Earnings Release |
| 10/05/2022 | FY 2021 Earnings Call |
| 10/05/2022 | FY 2021 Earnings Release |
| 30/03/2022 | Ex-dividend day for final dividend |
| 01/02/2022 | Q3 2021 Earnings Call |
| 01/02/2022 | Q3 2021 Earnings Release |
| 09/11/2021 | Interim 2021 Earnings Call |
| 09/11/2021 | Interim 2021 Earnings Release |
Past dividends on Kissei Pharmaceutical Co., Ltd.
| 28/03/2024 | Final Payment 41 JPY |
| 28/09/2023 | Interim Payment 41 JPY |
| 30/03/2023 | Final Payment 40 JPY |
| 29/09/2022 | Interim Payment 40 JPY |
| 30/03/2022 | Final Payment 28 JPY |
| 29/09/2021 | Interim Payment 28 JPY |
| 30/03/2021 | Final Payment 27 JPY |
| 29/09/2020 | Interim Payment 27 JPY |
| 30/03/2020 | Final Payment 26 JPY |
| 27/09/2019 | Interim Payment 26 JPY |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 72 297 73 330 -1.41% | 63 234 61 700 2.49% | 69 044 67 600 2.14% | 65 381 66 000 -0.94% | 67 493 68 700 -1.76% | 77 267 |
|
EBITDA Million JPY | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 4 653 9 377 -50.38% | 0,00 0,00 - | 0,00 0,00 - | 17 285 |
|
EBIT Million JPY | Released Forecast Spread | 6 202 7 260 -14.57% | 1 857 2 450 -24.2% | 1 505 750 100.67% | -1 402 -1 700 17.53% | -1 129 500 -325.8% | 5 767 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 7 121 8 220 -13.37% | 4 630 5 350 -13.46% | 7 476 6 050 23.57% | 16 507 4 700 251.21% | 13 680 14 100 -2.98% | 15 093 |
|
Net income Million JPY | Released Forecast Spread | 5 481 6 130 -10.59% | 2 817 3 850 -26.83% | 5 285 4 550 16.15% | 12 921 3 400 280.03% | 10 528 10 800 -2.52% | 11 433 |
|
EPS JPY | Released Forecast Spread | 117 128 -8.05% | 60,3 82,4 -26.81% | 113 97,6 16.03% | 280 72,9 284.36% | 228 234 -2.51% | 244 |
| Announcement Date | 08/05/19 | 12/05/20 | 11/05/21 | 10/05/22 | 08/05/23 | - |
Quarterly results
| Fiscal Period | March | 2020 S1 | 2021 S1 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2025 Q1 | 2025 S1 | 2026 S1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 31 548 30 700 2.76% | 32 284 31 200 3.47% | 32 388 32 200 0.58% | 17 697 | 16 285 15 650 4.06% | 16 579 15 450 7.31% | 32 864 31 225 5.25% | 18 771 | 19 313 17 750 8.81% | 36 978 36 800 0.48% | 20 881 | 20 500 | 42 500 | 43 000 | |
|
EBIT Million JPY | Released Forecast Spread | 2 334 1 300 79.54% | 2 044 700 192% | 270 -600 145% | -564 | 130 50,0 160% | -755 -300 -151.67% | -625 -50,0 -1150% | 1 117 | 1 633 700 133.29% | 2 015 2 000 0.75% | 2 149 | 2 100 | 5 200 | 4 800 | |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 2 870 | 5 711 | 7 273 6 373 14.12% | 1 440 | 2 141 2 700 -20.7% | 2 277 1 500 51.8% | 4 418 4 200 5.19% | 4 572 | 4 349 3 400 27.91% | 7 502 | 3 598 | ||||
|
Net income Million JPY | Released Forecast Spread | 2 150 1 300 65.38% | 4 396 1 600 174.75% | 5 666 5 100 11.1% | 1 153 200 476.5% | 1 635 2 040 -19.85% | 1 691 1 090 55.14% | 3 326 3 585 -7.22% | 3 341 | 3 265 2 288 42.7% | 5 678 5 900 -3.76% | 2 659 | 2 600 | 5 900 | 4 200 | |
|
EPS JPY | Released Forecast Spread | 46,0 27,8 65.61% | 94,1 34,2 175.2% | 123 93,3 31.69% | 25,0 4,00 525% | 35,5 44,3 -19.84% | 36,7 24,0 52.75% | 72,1 78,0 -7.47% | 72,5 | 71,0 49,7 42.76% | 52,7 51,4 2.53% | 124 131 -5.46% | 59,2 | 58,8 | 134 | 95,0 |
| Announcement Date | 06/11/19 | 05/11/20 | 09/11/21 | 01/02/22 | 01/08/22 | 08/11/22 | 08/11/22 | 31/01/23 | 31/07/23 | 06/11/23 | 06/11/23 | 30/01/24 | - | - | - |
| 07/05/2024 | KISSEI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
| 07/05/2024 | KYOWA KIRIN CO. LTD.: Q1 2024 Earnings Release |
| 07/05/2024 | CALLIDITAS THERAPEUTICS AB: Q1 2024 Earnings Release |
| 09/05/2024 01:35 am | SUPERNUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 | SK BIOPHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 10/05/2024 | OSCOTEC INC.: Q1 2024 Earnings Release (Projected) |
| 13/05/2024 | MEZZION PHARMA CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 15/05/2024 10:30 am | MERCK KGAA: Q1 2024 Earnings Release |
| 25/07/2024 | INDIVIOR PLC: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | KISSEI PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected) |
Past sector events for Kissei Pharmaceutical Co., Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4547 Stock
- Calendar Kissei Pharmaceutical Co., Ltd.
